Abnormal nuchal translucency followed by normal microarray analysis is associated with placental pathology‐related complications
Objective Identify placental pathology‐related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis. Methods A retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and...
Uloženo v:
| Vydáno v: | Prenatal diagnosis Ročník 41; číslo 7; s. 855 - 860 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Wiley Subscription Services, Inc
01.06.2021
|
| Témata: | |
| ISSN: | 0197-3851, 1097-0223, 1097-0223 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Objective
Identify placental pathology‐related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis.
Methods
A retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and a normal microarray analysis were matched to women with normal NT and a normal microarray analysis (2013–2019) in a single tertiary academic center. The following placental pathology‐related parameters were measured: preeclampsia, oligohydramnios, suspected intrauterine growth restriction, abnormal Doppler studies or small for gestational age (SGA) neonates. The primary outcome was defined as a composite of complications related to placental pathology including preeclampsia and SGA neonate. Secondary outcomes were labor complications and neonatal morbidity.
Results
A total of 185 women were included in the study: of them, 47 presented an abnormal NT (study group) and 138 presented normal NT (controls). Groups did not significantly differ in baseline characteristics. Regarding primary outcome, all placental‐related complications frequencies were higher in the study group, with a composite rate of 17.02% versus 6.52% in controls (p = 0.042%). Secondary outcomes did not differ between groups.
Conclusions
Abnormal NT measurement presented in pregnancies with normal fetal microarray analysis is associated with higher rates of placental‐related complications.
Key Points
What's already known about this topic?
Pathological NT is considered to be related to genetic anomalies.
What does this study add?
Pregnancies with increased nuchal translucency and no chromosomal anomalies using microarray analysis are associated with an increased risk for placental‐related disorders.
Practitioners should consider such pregnancies as high risk, and proper counseling should be given to the parents. |
|---|---|
| AbstractList | Identify placental pathology-related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis.OBJECTIVEIdentify placental pathology-related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis.A retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and a normal microarray analysis were matched to women with normal NT and a normal microarray analysis (2013-2019) in a single tertiary academic center. The following placental pathology-related parameters were measured: preeclampsia, oligohydramnios, suspected intrauterine growth restriction, abnormal Doppler studies or small for gestational age (SGA) neonates. The primary outcome was defined as a composite of complications related to placental pathology including preeclampsia and SGA neonate. Secondary outcomes were labor complications and neonatal morbidity.METHODSA retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and a normal microarray analysis were matched to women with normal NT and a normal microarray analysis (2013-2019) in a single tertiary academic center. The following placental pathology-related parameters were measured: preeclampsia, oligohydramnios, suspected intrauterine growth restriction, abnormal Doppler studies or small for gestational age (SGA) neonates. The primary outcome was defined as a composite of complications related to placental pathology including preeclampsia and SGA neonate. Secondary outcomes were labor complications and neonatal morbidity.A total of 185 women were included in the study: of them, 47 presented an abnormal NT (study group) and 138 presented normal NT (controls). Groups did not significantly differ in baseline characteristics. Regarding primary outcome, all placental-related complications frequencies were higher in the study group, with a composite rate of 17.02% versus 6.52% in controls (p = 0.042%). Secondary outcomes did not differ between groups.RESULTSA total of 185 women were included in the study: of them, 47 presented an abnormal NT (study group) and 138 presented normal NT (controls). Groups did not significantly differ in baseline characteristics. Regarding primary outcome, all placental-related complications frequencies were higher in the study group, with a composite rate of 17.02% versus 6.52% in controls (p = 0.042%). Secondary outcomes did not differ between groups.Abnormal NT measurement presented in pregnancies with normal fetal microarray analysis is associated with higher rates of placental-related complications.CONCLUSIONSAbnormal NT measurement presented in pregnancies with normal fetal microarray analysis is associated with higher rates of placental-related complications. What's already known about this topic? Pathological NT is considered to be related to genetic anomalies. What does this study add? Pregnancies with increased nuchal translucency and no chromosomal anomalies using microarray analysis are associated with an increased risk for placental‐related disorders. Practitioners should consider such pregnancies as high risk, and proper counseling should be given to the parents. ObjectiveIdentify placental pathology‐related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis.MethodsA retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and a normal microarray analysis were matched to women with normal NT and a normal microarray analysis (2013–2019) in a single tertiary academic center. The following placental pathology‐related parameters were measured: preeclampsia, oligohydramnios, suspected intrauterine growth restriction, abnormal Doppler studies or small for gestational age (SGA) neonates. The primary outcome was defined as a composite of complications related to placental pathology including preeclampsia and SGA neonate. Secondary outcomes were labor complications and neonatal morbidity.ResultsA total of 185 women were included in the study: of them, 47 presented an abnormal NT (study group) and 138 presented normal NT (controls). Groups did not significantly differ in baseline characteristics. Regarding primary outcome, all placental‐related complications frequencies were higher in the study group, with a composite rate of 17.02% versus 6.52% in controls (p = 0.042%). Secondary outcomes did not differ between groups.ConclusionsAbnormal NT measurement presented in pregnancies with normal fetal microarray analysis is associated with higher rates of placental‐related complications. Objective Identify placental pathology‐related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis. Methods A retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and a normal microarray analysis were matched to women with normal NT and a normal microarray analysis (2013–2019) in a single tertiary academic center. The following placental pathology‐related parameters were measured: preeclampsia, oligohydramnios, suspected intrauterine growth restriction, abnormal Doppler studies or small for gestational age (SGA) neonates. The primary outcome was defined as a composite of complications related to placental pathology including preeclampsia and SGA neonate. Secondary outcomes were labor complications and neonatal morbidity. Results A total of 185 women were included in the study: of them, 47 presented an abnormal NT (study group) and 138 presented normal NT (controls). Groups did not significantly differ in baseline characteristics. Regarding primary outcome, all placental‐related complications frequencies were higher in the study group, with a composite rate of 17.02% versus 6.52% in controls (p = 0.042%). Secondary outcomes did not differ between groups. Conclusions Abnormal NT measurement presented in pregnancies with normal fetal microarray analysis is associated with higher rates of placental‐related complications. Key Points What's already known about this topic? Pathological NT is considered to be related to genetic anomalies. What does this study add? Pregnancies with increased nuchal translucency and no chromosomal anomalies using microarray analysis are associated with an increased risk for placental‐related disorders. Practitioners should consider such pregnancies as high risk, and proper counseling should be given to the parents. Identify placental pathology-related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal microarray analysis. A retrospective study in which all women with singleton pregnancy who demonstrated NT above 3 mm and a normal microarray analysis were matched to women with normal NT and a normal microarray analysis (2013-2019) in a single tertiary academic center. The following placental pathology-related parameters were measured: preeclampsia, oligohydramnios, suspected intrauterine growth restriction, abnormal Doppler studies or small for gestational age (SGA) neonates. The primary outcome was defined as a composite of complications related to placental pathology including preeclampsia and SGA neonate. Secondary outcomes were labor complications and neonatal morbidity. A total of 185 women were included in the study: of them, 47 presented an abnormal NT (study group) and 138 presented normal NT (controls). Groups did not significantly differ in baseline characteristics. Regarding primary outcome, all placental-related complications frequencies were higher in the study group, with a composite rate of 17.02% versus 6.52% in controls (p = 0.042%). Secondary outcomes did not differ between groups. Abnormal NT measurement presented in pregnancies with normal fetal microarray analysis is associated with higher rates of placental-related complications. |
| Author | Kushnir, Anya Shemer, Asaf Yinon, Yoav Weisz, Boaz Rienstein, Shlomit Berkenstadt, Michal Krispin, Eyal |
| Author_xml | – sequence: 1 givenname: Eyal orcidid: 0000-0001-5859-9528 surname: Krispin fullname: Krispin, Eyal email: eyalkrispin@gmail.com organization: Sheba Medical Center – sequence: 2 givenname: Anya surname: Kushnir fullname: Kushnir, Anya organization: Sheba Medical Center – sequence: 3 givenname: Asaf surname: Shemer fullname: Shemer, Asaf organization: Tel Aviv University – sequence: 4 givenname: Shlomit surname: Rienstein fullname: Rienstein, Shlomit organization: Sheba Medical Center – sequence: 5 givenname: Michal surname: Berkenstadt fullname: Berkenstadt, Michal organization: Sheba Medical Center – sequence: 6 givenname: Yoav orcidid: 0000-0003-0702-370X surname: Yinon fullname: Yinon, Yoav organization: Sheba Medical Center – sequence: 7 givenname: Boaz surname: Weisz fullname: Weisz, Boaz organization: Sheba Medical Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33399234$$D View this record in MEDLINE/PubMed |
| BookMark | eNp10c1q3DAQB3BREprNtvQNiqGHBIpTffhLx5D0IxBoob2LsTzuKsiSK9ksvpU-QZ6xTxJld3NJKQhGh98MzH9OyZHzDgl5w-gFo5R_GLuLspHVC7JiVNY55VwckRVl6S-akp2Q0xjvEmy4rF-SEyGElFwUK_LnsnU-DGAzN-tNKlMAF-2s0ekl6721fotd1i7ZgQ1GBw8hwJKBA7tEE7P0IEavDUzJbs20yUYLacSUGkaYNt76n8vf3_cB7Y5oP4zWaJiMd_EVOe7BRnx9qGvy_dPHH1df8tuvn2-uLm9zLYqyynuGpaR9hQ2tKy151SOyWkpaclFTjU3bUy1FW_QSNHQa66pKlGrgskWxJuf7qWPwv2aMkxpM1GgtOPRzVLyoSyGLIiW3Ju-e0Ts_h7RsUmXBuKikbJJ6e1BzO2CnxmAGCIt6yjaBfA9SYDEG7JU2027llLGxilH1eDs1durxdsmfPfNPI_-V7_dyaywu_2Pq2_VOPwAK6qoZ |
| CitedBy_id | crossref_primary_10_1055_a_1534_2599 crossref_primary_10_7759_cureus_46969 crossref_primary_10_3390_diagnostics13010048 |
| Cites_doi | 10.1016/j.ajog.2004.03.090 10.1016/S0140-6736(05)17987-2 10.1002/uog.4044 10.1016/j.ajog.2006.06.006 10.1097/01.AOG.0000191301.63871.c6 10.1016/S1028-4559(10)60029-0 10.1007/s00404-018-4790-9 10.1046/j.1469-0705.1995.05010015.x 10.1080/14767050802676717 10.1016/j.ajog.2014.06.025 10.1159/000053941 10.1093/humupd/dmg008 10.1095/biolreprod.102.014977 10.1002/uog.20 10.1002/uog.14880 10.1016/j.bpobgyn.2013.10.004 10.1016/j.ijgo.2007.02.010 10.1016/j.ajog.2004.12.093 10.1515/jpme.1990.18.3.165 10.1016/j.ajog.2004.09.019 10.1016/S0002-9378(84)90359-4 10.1002/pd.4586 10.1053/j.semperi.2005.06.001 10.1016/j.ajog.2014.10.1102 |
| ContentType | Journal Article |
| Copyright | 2021 John Wiley & Sons Ltd. |
| Copyright_xml | – notice: 2021 John Wiley & Sons Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7T5 7T7 7TK 7TM 8FD C1K FR3 H94 K9. P64 RC3 7X8 |
| DOI | 10.1002/pd.5896 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Nucleic Acids Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef Genetics Abstracts MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-0223 |
| EndPage | 860 |
| ExternalDocumentID | 33399234 10_1002_pd_5896 PD5896 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WH7 WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WXI WXSBR WYISQ XG1 XV2 ZGI ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7QP 7T5 7T7 7TK 7TM 8FD C1K FR3 H94 K9. P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c3456-f1e590f6e8076c926fee1799052370ce8bf0c93b4f9acadce7668070ca29be3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000611178200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0197-3851 1097-0223 |
| IngestDate | Thu Jul 10 21:56:54 EDT 2025 Wed Nov 19 11:11:11 EST 2025 Wed Feb 19 02:27:14 EST 2025 Sat Nov 29 06:25:32 EST 2025 Tue Nov 18 21:51:29 EST 2025 Wed Jan 22 16:28:30 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | nuchal translucency placental complications fetus chromosomal microarray analysis |
| Language | English |
| License | 2021 John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3456-f1e590f6e8076c926fee1799052370ce8bf0c93b4f9acadce7668070ca29be3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-5859-9528 0000-0003-0702-370X |
| PMID | 33399234 |
| PQID | 2541236998 |
| PQPubID | 1016448 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_2475394422 proquest_journals_2541236998 pubmed_primary_33399234 crossref_citationtrail_10_1002_pd_5896 crossref_primary_10_1002_pd_5896 wiley_primary_10_1002_pd_5896_PD5896 |
| PublicationCentury | 2000 |
| PublicationDate | June 2021 2021-06-00 2021-Jun 20210601 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: June 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Charlottesville |
| PublicationTitle | Prenatal diagnosis |
| PublicationTitleAlternate | Prenat Diagn |
| PublicationYear | 2021 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2015; 35 2009; 22 2005; 192 1990; 18 2006; 195 2004 2014; 28 2007; 30 2007; 98 2005; 29 1995; 5 2014; 211 1984; 150 2015; 46 2018; 298 2010; 49 2004; 191 2005; 365 2015; 212 2003; 9 2003; 69 2005; 7 2005; 76 2001; 16 2006; 107 2003; 21 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 Nicolaides KH (e_1_2_7_11_1) 2005; 76 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_12_1 Dollberg S (e_1_2_7_14_1) 2005; 7 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_25_1 e_1_2_7_24_1 Nicolaïdes K (e_1_2_7_13_1) 2004 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 |
| References_xml | – volume: 365 start-page: 785 year: 2005 end-page: 799 article-title: Pre‐eclampsia publication-title: Lancet – volume: 30 start-page: 11 year: 2007 end-page: 18 article-title: Increased nuchal translucency thickness and normal karyotype: time for parental reassurance publication-title: Ultrasound Obstet Gynecol – volume: 49 start-page: 133 year: 2010 end-page: 138 article-title: Pathophysiology of increased fetal nuchal translucency thickness publication-title: Taiwan J Obstet Gynecol – volume: 7 start-page: 311 year: 2005 end-page: 314 article-title: Birth weight standards in the live‐born population in Israel publication-title: Isr Med Assoc J – volume: 16 start-page: 360 year: 2001 end-page: 363 article-title: Pregnancy outcome and prognosis in fetuses with increased first‐trimester nuchal translucency publication-title: Fetal Diagn Ther – volume: 212 year: 2015 article-title: Risk of critical congenital heart defects by nuchal translucency norms publication-title: Am J Obstet Gynecol – volume: 18 start-page: 165 year: 1990 end-page: 172 article-title: Normal values of pulsatility index from fetal vessels: a cross‐sectional study on 1556 healthy fetuses publication-title: J Perinat Med – volume: 192 start-page: 937 year: 2005 end-page: 944 article-title: Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy publication-title: Am J Obstet Gynecol – volume: 46 start-page: 650 year: 2015 end-page: 658 article-title: Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysis publication-title: Ultrasound Obstet Gynecol – volume: 98 start-page: 5 year: 2007 end-page: 9 article-title: Nuchal translucency as a predictor of adverse pregnancy outcome publication-title: Int J Gynecol Obstet – volume: 211 year: 2014 article-title: Risk of selected structural abnormalities in infants after increased nuchal translucency measurement publication-title: Am J Obstet Gynecol – volume: 9 start-page: 175 year: 2003 end-page: 184 article-title: Pathophysiology of increased nuchal translucency: a review of the literature publication-title: Hum Reprod Update – volume: 35 start-page: 517 year: 2015 end-page: 528 article-title: Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms publication-title: Prenat Diagn – volume: 5 start-page: 15 year: 1995 end-page: 19 article-title: Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency publication-title: Ultrasound Obstet Gynecol – volume: 29 start-page: 190 year: 2005 end-page: 194 article-title: First‐trimester screening for chromosomal abnormalities publication-title: Semin Perinatol – volume: 150 start-page: 245 year: 1984 end-page: 249 article-title: Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome publication-title: Am J Obstet Gynecol – volume: 195 start-page: 843 year: 2006 end-page: 847 article-title: Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? publication-title: Am J Obstet Gynecol – volume: 69 start-page: 1 year: 2003 end-page: 7 article-title: Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia publication-title: Biol Reprod – volume: 28 start-page: 355 year: 2014 end-page: 366 article-title: Increased nuchal translucency with normal karyotype and anomaly scan: what next? publication-title: Best Pract Res Clin Obstet Gynaecol – volume: 22 start-page: 479 year: 2009 end-page: 484 article-title: A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses publication-title: J Matern Neonatal Med – volume: 298 start-page: 97 year: 2018 end-page: 101 article-title: Association between unexplained thickened nuchal translucency and adverse pregnancy outcomes publication-title: Arch Gynecol Obstet – year: 2004 – volume: 107 start-page: 6 year: 2006 end-page: 10 article-title: Relation between increased fetal nuchal translucency thickness and chromosomal defects publication-title: Obstet Gynecol – volume: 192 start-page: 1005 year: 2005 end-page: 1021 article-title: Increased nuchal translucency with normal karyotype publication-title: Am J Obstet Gynecol – volume: 191 start-page: 45 year: 2004 end-page: 67 article-title: Nuchal translucency and other first‐trimester sonographic markers of chromosomal abnormalities publication-title: Am J Obstet Gynecol – volume: 76 start-page: 593 year: 2005 end-page: 601 article-title: Increased nuchal translucency with normal karyotype publication-title: Ginekol Pol – volume: 21 start-page: 124 year: 2003 end-page: 127 article-title: The cerebroplacental Doppler ratio revisited publication-title: Ultrasound Obstet Gynecol – ident: e_1_2_7_19_1 doi: 10.1016/j.ajog.2004.03.090 – ident: e_1_2_7_22_1 doi: 10.1016/S0140-6736(05)17987-2 – ident: e_1_2_7_24_1 doi: 10.1002/uog.4044 – ident: e_1_2_7_8_1 doi: 10.1016/j.ajog.2006.06.006 – ident: e_1_2_7_4_1 doi: 10.1097/01.AOG.0000191301.63871.c6 – ident: e_1_2_7_10_1 doi: 10.1016/S1028-4559(10)60029-0 – ident: e_1_2_7_28_1 doi: 10.1007/s00404-018-4790-9 – ident: e_1_2_7_7_1 doi: 10.1046/j.1469-0705.1995.05010015.x – ident: e_1_2_7_27_1 doi: 10.1080/14767050802676717 – ident: e_1_2_7_5_1 doi: 10.1016/j.ajog.2014.06.025 – ident: e_1_2_7_3_1 doi: 10.1159/000053941 – ident: e_1_2_7_9_1 doi: 10.1093/humupd/dmg008 – ident: e_1_2_7_12_1 doi: 10.1095/biolreprod.102.014977 – ident: e_1_2_7_17_1 doi: 10.1002/uog.20 – ident: e_1_2_7_25_1 doi: 10.1002/uog.14880 – ident: e_1_2_7_20_1 doi: 10.1016/j.bpobgyn.2013.10.004 – ident: e_1_2_7_26_1 doi: 10.1016/j.ijgo.2007.02.010 – volume-title: The 11‐13+6 Weeks Scan year: 2004 ident: e_1_2_7_13_1 – ident: e_1_2_7_23_1 doi: 10.1016/j.ajog.2004.12.093 – volume: 76 start-page: 593 year: 2005 ident: e_1_2_7_11_1 article-title: Increased nuchal translucency with normal karyotype publication-title: Ginekol Pol – volume: 7 start-page: 311 year: 2005 ident: e_1_2_7_14_1 article-title: Birth weight standards in the live‐born population in Israel publication-title: Isr Med Assoc J – ident: e_1_2_7_16_1 doi: 10.1515/jpme.1990.18.3.165 – ident: e_1_2_7_18_1 doi: 10.1016/j.ajog.2004.09.019 – ident: e_1_2_7_15_1 doi: 10.1016/S0002-9378(84)90359-4 – ident: e_1_2_7_21_1 doi: 10.1002/pd.4586 – ident: e_1_2_7_2_1 doi: 10.1053/j.semperi.2005.06.001 – ident: e_1_2_7_6_1 doi: 10.1016/j.ajog.2014.10.1102 |
| SSID | ssj0028297 |
| Score | 2.3256824 |
| Snippet | Objective
Identify placental pathology‐related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT)... What's already known about this topic? Pathological NT is considered to be related to genetic anomalies. What does this study add? Pregnancies with increased... Identify placental pathology-related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT) with normal... ObjectiveIdentify placental pathology‐related complications, labor and neonatal outcomes in pregnancies complicated by pathological nuchal translucency (NT)... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 855 |
| SubjectTerms | Adult chromosomal microarray analysis Cohort Studies Complications Female fetus Fetuses Humans Infant, Newborn Labor Middle Aged Morbidity Neonates nuchal translucency Nuchal Translucency Measurement - instrumentation Nuchal Translucency Measurement - methods Nuchal Translucency Measurement - statistics & numerical data Pathology Placenta Placenta - pathology placental complications Pre-eclampsia Preeclampsia Pregnancy Pregnancy Outcome - epidemiology Retrospective Studies Small-for-gestational age Tissue Array Analysis - methods Tissue Array Analysis - statistics & numerical data |
| Title | Abnormal nuchal translucency followed by normal microarray analysis is associated with placental pathology‐related complications |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpd.5896 https://www.ncbi.nlm.nih.gov/pubmed/33399234 https://www.proquest.com/docview/2541236998 https://www.proquest.com/docview/2475394422 |
| Volume | 41 |
| WOSCitedRecordID | wos000611178200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1097-0223 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0028297 issn: 0197-3851 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LixQxEC7cWREvvh-t6xJh8dZuOsl0OsfFdfCwLosv5tbkicLYM8xD2Zv4C_yN_hJT6WzrsAiC0BCartBNV1VSVan6CuDAj6lztnJl7Z0ohWl42Yh0KwyjnHudWrJ8OJGnp810qs7-aPXV40MMATfUjLReo4Jrszr8DRq6cM_Hjap3YJdFqRUj2D1-M3l_MnhbWDPa10pHLYp2RV8xi5MP89TtreiSfbltrqb9ZnLzP770FtzIRiY56qXiNlzx3R249jofo9-F70emQ1t1RrqN_RiHNe5Ys8jluNSSEEVj_tU7Ys5JJvuMaXt6udTnRGcUExIvnXkbaTGeS1KCF5ZXEmx0nAL2P7_9SOUykWQre_0evJ28fPfiVZmbMZSWRyOrDJUfKxpq31BZW8Xq4D2iyWFYWVLrGxOoVdyIoLTVznpZ15GUWs2U8fw-jLp55x8CqbzUQVIWpUeLOlTac-qYHDOpTKiCKuDZBVdam3HKsV3GrO0Rllm7cC3-zwLIQLjooTkuk-xdsLXNurlqo0uMkDPRzyzg6fA4ahUelejOzzeRRkQ3TgnBWAEPenEY3sE5gvlyUcBB4vrfXt6eHePw6N_IHsN1hukyKcCzB6P1cuOfwFX7Zf1ptdyHHTlt9rOI_wKt7wKQ |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB_0KuqL3x_RqisU32KT3c3HPhbrUfF6FK3St7DZDxTO3HG9U_om_gX-jf4lzmy2kaMIghBYQmZJyMzszszO_AZgxxWZtSa3aemsTGVbi7SW4Va2PBPC6dCS5eOkmk7rkxN1FLMqqRamx4cYAm6kGWG9JgWngPTuH9TQhX1Z1Kq8DFsShagYwdb-u_GHyeBuUdFoXyyNaoSGRV8yS5N349TNveiCgblpr4YNZ3zzfz71FtyIZibb6-XiNlxy3R24ehgP0u_Cj722I2t1xrq1-YTDivasGfIZF1vmUTjm35xl7RmLZF8ocU8vl_qM6YhjwvDSkbtISxFdFlK8qMCSUavjELL_9f1nKJhBko389Xvwfvz6-NVBGtsxpEagmZX63BUq86Wrs6o0ipfeOcKTo8BylRlXtz4zSrTSK220Na4qSyTNjOaqdeI-jLp55x4Cy12lfZVxlB8tS59rJzLLq4JXqvW5Vwm8OGdLYyJSOTXMmDU9xjJvFrah_5kAGwgXPTjHRZLtc742UTtPG3SKCXQGPc0Eng-PUa_osER3br5GGomOnJKS8wQe9PIwvEMIgvMVMoGdwPa_vbw52qfh0b-RPYNrB8eHk2byZvr2MVznlDwTwj3bMFot1-4JXDFfV59Pl0-jpP8G_TAFmA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEB_0Tg5f_D6tnhrh8K1emqRp83i4LorrsvjFvZU0Hyis3WVvV7k38S_wb_QvMZPmKsshCEIhlE5o6cwkM5OZ3wAcupJaawqbS2dFLtqa57WIt6JllHOnY0uWj5NqOq1PTtQsZVViLUyPDzEE3FAz4nqNCu6W1h_9QQ1d2mdlreRl2BWlkkEpd0dvxx8mg7uFRaN9sXRQo2BY9CWzOPkoTd3eiy4YmNv2atxwxtf_51NvwLVkZpLjXi5uwiXX3YK9N-kg_Tb8OG47tFbnpNuYT2FY4541D3wOiy3xQTgW35wl7RlJZF8wcU-vVvqM6IRjQsKlE3cDLUZ0SUzxwgJLgq2OY8j-1_efsWAmkGzlr9-Bd-MX75-_zFM7htzwYGblvnClol66mlbSKCa9c4gnh4HlihpXt54axVvhlTbaGldJGUip0Uy1ju_DTrfo3D0ghau0rygL8qOF9IV2nFpWlaxSrS-8yuDpOVsak5DKsWHGvOkxllmztA3-zwzIQLjswTkukhyc87VJ2nnaBKcYQWeCp5nBk-Fx0Cs8LNGdW2wCjQiOnBKCsQzu9vIwvINzhPPlIoPDyPa_vbyZjXC4_29kj2FvNho3k1fT1w_gKsPcmRjtOYCd9WrjHsIV83X9-XT1KAn6b4KqBRM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abnormal+nuchal+translucency+followed+by+normal+microarray+analysis+is+associated+with+placental+pathology%E2%80%90related+complications&rft.jtitle=Prenatal+diagnosis&rft.au=Krispin%2C+Eyal&rft.au=Kushnir%2C+Anya&rft.au=Shemer%2C+Asaf&rft.au=Rienstein%2C+Shlomit&rft.date=2021-06-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0197-3851&rft.eissn=1097-0223&rft.volume=41&rft.issue=7&rft.spage=855&rft.epage=860&rft_id=info:doi/10.1002%2Fpd.5896&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0197-3851&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0197-3851&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0197-3851&client=summon |